X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (395) 395
Publication (90) 90
Patent (7) 7
Magazine Article (5) 5
Book Chapter (4) 4
Book Review (2) 2
Conference Proceeding (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (151) 151
index medicus (150) 150
cancer (149) 149
oncology (107) 107
life sciences (102) 102
animals (91) 91
chemotherapy (88) 88
female (79) 79
male (63) 63
immunology (59) 59
mice (58) 58
middle aged (53) 53
aged (51) 51
colorectal cancer (44) 44
tumors (44) 44
[ sdv.can ] life sciences [q-bio]/cancer (43) 43
neoplasms - immunology (43) 43
immunotherapy (39) 39
cell line, tumor (38) 38
dendritic cells (37) 37
adult (31) 31
antineoplastic combined chemotherapy protocols - therapeutic use (31) 31
prognosis (31) 31
research (30) 30
t cells (30) 30
treatment outcome (30) 30
care and treatment (29) 29
cell biology (29) 29
apoptosis (27) 27
survival (27) 27
metastasis (26) 26
regulatory t-cells (26) 26
analysis (25) 25
antineoplastic agents - therapeutic use (24) 24
health aspects (24) 24
medicine, research & experimental (23) 23
oxaliplatin (23) 23
antineoplastic agents - pharmacology (21) 21
bevacizumab (21) 21
mice, inbred c57bl (21) 21
colorectal neoplasms - drug therapy (20) 20
t-cells (20) 20
5-fluorouracil (19) 19
aged, 80 and over (19) 19
cell death (19) 19
dendritic cells - immunology (19) 19
expression (19) 19
fluorouracil (19) 19
irinotecan (19) 19
melanoma (19) 19
neoplasms - drug therapy (19) 19
retrospective studies (19) 19
colon cancer (18) 18
colorectal-cancer (18) 18
immune response (18) 18
cells (17) 17
cyclophosphamide (17) 17
immune system (17) 17
mice, inbred balb c (17) 17
antineoplastic agents (16) 16
disease-free survival (16) 16
human health and pathology (16) 16
multidisciplinary sciences (16) 16
biochemistry & molecular biology (15) 15
colorectal neoplasms - pathology (15) 15
fluorouracil - administration & dosage (15) 15
lymphocytes (15) 15
surgery (15) 15
breast cancer (14) 14
camptothecin - analogs & derivatives (14) 14
cisplatin (14) 14
cytotoxicity (14) 14
death (14) 14
gastroenterology & hepatology (14) 14
medicine & public health (14) 14
neoplasms - therapy (14) 14
patients (14) 14
physiological aspects (14) 14
radiotherapy (14) 14
1st-line treatment (13) 13
antineoplastic combined chemotherapy protocols - adverse effects (13) 13
calreticulin exposure (13) 13
camptothecin - administration & dosage (13) 13
chemical and pharmacologic phenomena (13) 13
immunogenicity (13) 13
in-vivo (13) 13
lymphocytes t (13) 13
metastases (13) 13
organoplatinum compounds - administration & dosage (13) 13
rats (13) 13
t-lymphocytes, regulatory - immunology (13) 13
therapy (13) 13
apoptosis - drug effects (12) 12
biochemistry (12) 12
deoxycytidine - analogs & derivatives (12) 12
inflammation (12) 12
kaplan-meier estimate (12) 12
mice, nude (12) 12
neoplasm metastasis (12) 12
open-label (12) 12
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Nature Medicine, ISSN 1078-8956, 01/2013, Volume 19, Issue 1, pp. 57 - 64
Chemotherapeutic agents are widely used for cancer treatment. In addition to their direct cytotoxic effects, these agents harness the host's immune system,... 
MEDICINE, RESEARCH & EXPERIMENTAL | CANCER-CHEMOTHERAPY | ANGIOGENESIS | BIOCHEMISTRY & MOLECULAR BIOLOGY | GEMCITABINE | BETA | CELL BIOLOGY | 5-FLUOROURACIL | INHIBITION | MICROENVIRONMENT | ANTITUMOR IMMUNITY | BEARING MICE | T-CELLS | Neoplasms - metabolism | Cell Proliferation | Inflammasomes - metabolism | NLR Family, Pyrin Domain-Containing 3 Protein | Cathepsin B - genetics | Humans | Caspase 1 - metabolism | Deoxycytidine - pharmacology | Signal Transduction - immunology | Neoplasms - genetics | RNA Interference | Female | Antineoplastic Agents - pharmacology | Interleukin-1beta - biosynthesis | Dendritic Cells - metabolism | bcl-2-Associated X Protein - genetics | Interleukin-17 - secretion | Mice, Inbred C57BL | CD4-Positive T-Lymphocytes - metabolism | Cathepsin B - metabolism | Mice, Knockout | Carrier Proteins - genetics | Macrophages - metabolism | Animals | Carrier Proteins - metabolism | Caspase 1 - genetics | Cell Line, Tumor | Fluorouracil - pharmacology | Mice | Mice, Inbred BALB C | RNA, Small Interfering | Receptors, Interleukin-1 - antagonists & inhibitors | Deoxycytidine - analogs & derivatives | Chemotherapy | Gemcitabine | Cathepsins | Physiological aspects | Dosage and administration | Research | Health aspects | Fluorouracil | Cancer | Cells | Inflammatory diseases | Tumors | Engineering Sciences | Automatic
Journal Article
Science, ISSN 0036-8075, 01/2018, Volume 359, Issue 6371, pp. 91 - 97
Immune checkpoint inhibitors (ICIs) targeting the PD-1/PD-L1 axis induce sustained clinical responses in a sizable minority of cancer patients. We found that... 
CELL LUNG-CANCER | MELANOMA | MICROENVIRONMENT | INTESTINAL MICROBIOTA | CYCLOPHOSPHAMIDE | PD-1 BLOCKADE | MULTIDISCIPLINARY SCIENCES | GENES | RESISTANCE | ANTITUMOR IMMUNITY | NIVOLUMAB | CD4 Antigens - immunology | Immunotherapy - methods | Humans | Antibodies, Monoclonal - therapeutic use | Programmed Cell Death 1 Receptor - antagonists & inhibitors | Gastrointestinal Microbiome - genetics | Fecal Microbiota Transplantation | Anti-Bacterial Agents - therapeutic use | Feces - microbiology | Metagenome - genetics | Neoplasms - therapy | Animals | Receptors, CCR - immunology | Interleukin-12 - immunology | Receptors, CXCR3 - immunology | T-Lymphocytes - immunology | Mice | Gastrointestinal Microbiome - immunology | Verrucomicrobia - genetics | Verrucomicrobia - immunology | Care and treatment | Cell receptors | Microbiota (Symbiotic organisms) | Immunotherapy | Epithelial tumors | Physiological aspects | Health aspects | Methods | Apoptosis | PD-1 protein | Interleukin | Microbiomes | Transplantation | Lymphocytes T | Anticancer properties | Microbiota | Lymphocytes | Bacteria | Feces | Supplementation | Gnotobiotics | Kidneys | Melanoma | Dietary supplements | Interleukin 12 | Abundance | CXCR3 protein | Patients | CD4 antigen | Immune checkpoint | Antibiotics | Lungs | Flora | PD-L1 protein | Relative abundance | Antitumor activity | CCR9 protein | Tumors | Kidney transplantation | Cancer | Life Sciences
Journal Article
Journal of Clinical Investigation, ISSN 0021-9738, 02/2010, Volume 120, Issue 2, pp. 457 - 471
Journal Article
Breast Cancer Research and Treatment, ISSN 0167-6806, 1/2011, Volume 125, Issue 1, pp. 65 - 72
Journal Article
The Lancet Oncology, ISSN 1470-2045, 08/2018, Volume 19, Issue 8, pp. 1094 - 1106
Journal Article
Bulletin du Cancer, ISSN 0007-4551, 12/2018, Volume 105, pp. S101 - S112
Novel strategy in oncoimmunology: Recent advances in immuno-oncology with the development of anti-PD1/PD-L1 antibodies are revolutionizing oncological... 
Biomarkers | Checkpoint inhibitors | Immunotherapy
Journal Article
OncoImmunology, ISSN 2162-4011, 02/2016, Volume 5, Issue 2, p. e1054598
Tumor-infiltrating T and B lymphocytes could have the potential to affect cancer prognosis. The objective of this study was to investigate the prognostic... 
B cells | gastric cancer | histology | human tumors | prognosis | T-bet | Life Sciences | Immunology | Cancer
Journal Article
Journal Article
Journal Article
Journal of Experimental Medicine, ISSN 0022-1007, 10/2005, Volume 202, Issue 8, pp. 1075 - 1085
Journal Article
Cancer Research, ISSN 0008-5472, 04/2009, Volume 69, Issue 8, pp. 3563 - 3569
Journal Article